KNSA - Kiniksa Pharmaceuticals, Ltd.

QQQ $ 474.86 $ 2.12 (0.45 %)

DIA $ 414.87 $ 2.97 (0.72 %)

SPY $ 561.82 $ 2.92 (0.52 %)

TLT $ 100.40 $ 0.27 (0.27 %)

GLD $ 238.66 $ 2.35 (0.99 %)

Previous Close

$ 25.26

Open

$ 26.13

Bid

$ 25.26 x 100

Ask

$ 25.26 x 100

Day's Range

$ 24.91 - $ 26.13

52 Week Range

$ 14.12 - $ 27.92

Volume

310,466

Average Volume

Market Cap

3.6B

Beta (5Y Monthly)

$ 0.48

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-25-2024	06-30-2024	10-Q
2	04-25-2024	03-31-2024	10-Q
3	02-28-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-01-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	03-02-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-24-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	02-25-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-04-2020	06-30-2020	10-Q
18	05-04-2020	03-31-2020	10-Q
19	03-05-2020	12-31-2019	10-K
20	11-05-2019	09-30-2019	10-Q
21	08-13-2019	06-30-2019	10-Q
22	05-07-2019	03-31-2019	10-Q
23	03-12-2019	12-31-2018	10-K
24	11-06-2018	09-30-2018	10-Q
25	08-06-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Jefferies Initiates Coverage On Kiniksa Ph...
09/13/2024 13:04:53

Jefferies analyst Roger Song initiates coverage on Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Buy rating and announces Pri...

why-comcast-shares-are-trading-lower-by-6-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Comcast Shares Are Trading Lower By 6%...
07/23/2024 17:21:51

Wedbush Maintains Outperform on Kiniksa Ph...
07/23/2024 16:55:07

Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Outperform and raises the price ta...

danaher-posts-upbeat-earnings-joins-spotify-msci-owens--minor-and-other-big-stocks-moving-higher-on-tuesday

Danaher Posts Upbeat Earnings, Joins Spoti...
07/23/2024 15:04:22

Kiniksa Expects 2024 Arcalyst Net Product ...
07/23/2024 11:35:56

Kiniksa Pharmaceuticals Q2 2024 GAAP EPS $...
07/23/2024 11:31:45

Kiniksa Pharmaceuticals Commences Enrollme...
07/09/2024 12:04:18

Kiniksa Pharmaceuticals Sponsors American ...
06/17/2024 12:37:01

– Initiative aimed at improving access and outcomes for patients with recurrent pericarditis – – American Heart Association to ...

Kiniksa Pharmaceuticals - Expects Redomici...
06/14/2024 20:32:15

-SEC Filing

Wells Fargo Initiates Coverage On Kiniksa ...
05/03/2024 15:48:59

Wells Fargo analyst Eva Fortea Verdejo initiates coverage on Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Overweight rating ...

JP Morgan Maintains Overweight on Kiniksa ...
05/01/2024 14:47:44

JP Morgan analyst Anupam Rama maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Overweight and raises the price target ...

Evercore ISI Group Maintains Outperform on...
04/24/2024 17:39:50

Evercore ISI Group analyst Liisa Bayko maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Outperform and raises the pric...

Kiniksa Expects 2024 Arcalyst Net Product ...
04/23/2024 11:33:50

Kiniksa Pharmaceuticals Q1 2024 GAAP EPS $...
04/23/2024 11:32:43

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimat...

Earnings Scheduled For April 23, 2024
04/23/2024 10:56:59

Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of...

Kiniksa Expects 2024 ARCALYST Net Product ...
02/28/2024 12:31:51

Financial GuidanceKiniksa expects 2024 ARCALYST net product revenue of between $360 million and $380 million.Kiniksa expects th...

Kiniksa Pharmaceuticals Q4 EPS $0.35 Beats...
02/28/2024 12:31:01

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate ...

Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

Earnings Outlook For Kiniksa Pharmaceuticals
02/27/2024 18:00:56

Kiniksa Pharmaceuticals Says ARCALYST (ril...
01/04/2024 12:48:09